Pituitary metastases: current practice in Japan.

CONCLUSIONS At the time of this writing, approximately 60% (120/201) of PMs had been treated by stereotactic radiation therapy in Japan. The median survival time was much longer than that reported in past series. To confirm the changes of clinical features and medical practice, a prospective and population-based survey is mandatory.
PMID: 26186025 [PubMed - as supplied by publisher]

Source: Journal of Neurosurgery - July 17, 2015 Category: Neurosurgery Authors: Habu M, Tokimura H, Hirano H, Yasuda S, Nagatomo Y, Iwai Y, Kawagishi J, Tatewaki K, Yunoue S, Campos F, Kinoshita Y, Shimatsu A, Teramoto A, Arita K Tags: J Neurosurg Source Type: research